BMY

NYSE

BRISTOL MYERS SQUIBB CO

Health Care, Pharmaceuticals

$64.72

close 7 Aug 2026

+40.91%

52-week change

$132.20B

market cap

$42.52

$68.10

52-week range

Expected price

$74.17 – $90.65

Current price

$64.72

Signal

Could be undervalued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)14.22x

P/S (TTM)2.69x

P/B5.92x

EV/EBITDA (TTM)9.66x

FCF yield (TTM)8.65%

PEG (TTM, GAAP)2.61

Context

P/E, own 5-year average18.90x

P/E, sector median29.65x*

Price at 5-year median P/E$82.96*

Indicated dividend yield3.89%

Forward — analyst consensus

Forward P/E (FY2026)9.32x*

Forward P/E (FY2027)9.88x

Forward PEG—*

Consensus EPS FY2026 (25 analysts)$6.95

EPS growth (FY2026→FY2027)-5.71%

Revenue growth (FY2026)3.43%

Street view

Price target (mean)$66.21*

Target upside2.30%

Ratings (buy / hold / sell)10 / 17 / 1

FY2026 EPS revisions, 30d (up / down)12 / 6

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 30 Jun 2026, filed 30 Jul 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR -0.69%10Y CAGR +25.89%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$64.72

Cash & equivalents$8.72B

Total debt$42.86B

Shares outstanding2.04B

Result

DCF price per share$64.74

Current price$64.72

Margin of safety+0.03%

PV of years 1–10$74.23B

PV of terminal value$92.15B

Equity value$132.24B

Market-implied growth-0.69%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$11.36B	$11.28B	$11.20B	$11.13B	$11.05B	$10.97B	$10.90B	$10.82B	$10.75B	$10.67B	$198.94B
PV	$10.52B	$9.67B	$8.89B	$8.18B	$7.52B	$6.92B	$6.36B	$5.85B	$5.38B	$4.94B	$92.15B

period to 30 Jun 2026, filed 30 Jul 2026, close 7 Aug 2026